Ling Xiang
Director/Board Member chez YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Profil
Ling Xiang is currently serving as an Independent Director at Guangdong Zhongnan Iron & Steel Co., Ltd., as well as an Independent Non-Executive Director at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Dr. Xiang is also a Director at HEC Pharm Co., Ltd.
and will assume the role of Independent Director at GHT Co., Ltd.
in 2023.
Dr. Xiang completed their graduate degree at Hunan Normal University in 2003 and obtained graduate and doctorate degrees from Sun Yat-Sen University in 2006 and 2013, respectively.
Postes actifs de Ling Xiang
Sociétés | Poste | Début |
---|---|---|
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Director/Board Member | 05/06/2020 |
GUANGDONG ZHONGNAN IRON AND STEEL CO., LTD. | Director/Board Member | 25/06/2019 |
GHT CO.,LTD | Director/Board Member | 21/12/2023 |
HEC Pharm Co., Ltd.
HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Director/Board Member | - |
Formation de Ling Xiang
Hunan Normal University | Graduate Degree |
Sun Yat-Sen University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
GUANGDONG ZHONGNAN IRON AND STEEL CO., LTD. | Non-Energy Minerals |
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Health Technology |
GHT CO.,LTD | Electronic Technology |
Entreprise privées | 1 |
---|---|
HEC Pharm Co., Ltd.
HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Health Technology |